Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Progenity Asks Court to Declare Non-Infringement of Natera Patents

Progenity Asks Court to Declare Non-Infringement of Natera Patents

Jul 07, 2020
|
staff reporter

NEW YORK – Progenity is seeking a declaratory judgment from a court that the in-house use of its Innatal noninvasive prenatal test and related activities do not infringe six patents held by Natera.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Molecular Diagnostics

  1. Roche Continues Expanding Diagnostic Portfolio for SARS-CoV-2 and Beyond

    Premium

  2. Coronavirus Testing Specimen Collection Devices From DNA Genotek, Clinical Enterprises Get FDA EUAs

  3. CMS Colon Cancer Screening Memo Bodes Well for Assays in Development; Denies Epi ProColon

  4. FDA Reissues Emergency Use Authorization for Thermo Fisher Scientific COVID-19 Combo Kit

  5. Fluidigm Shares Rise on Selection of Saliva-Based COVID-19 Assay for Federal Surge Testing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.